Authors : Apiyanteide F; Nabai O.E; Adika V.O; Boss J.S; Danjuma I

Volume/Issue : Volume 9 - 2024, Issue 5 - May

Google Scholar : https://tinyurl.com/3jes24x4

Scribd : https://tinyurl.com/9m9kc48r

DOI : https://doi.org/10.38124/ijisrt/IJISRT24MAY328

Abstract : Measles is an issue of public health concern responsible for outbreaks and death of children especially in Sub-Saharan Africa. This study sought to determine the effectiveness of mass vaccination against measles in Yobe State, Northeast Nigeria. An ecological epidemiological study design involving the collection of secondary data from the same population was carried out over a period of two years. These data were collected from Epidemiology Unit of Yobe State Primary Healthcare Development Board from the Integrated Disease Surveillance Response database which collects records of notifiable diseases in Nigeria. All cases of measles within the period under review (2016-2017) were included and a comparison of the number of cases and deaths from measles reported in two different periods before supplementary immunization activity or mass vaccination against measles (2016) and after supplementary immunization activity against measles in the state (2017) was done. The mass vaccination intervention was conducted within first week of January 2017 as a measure to address outbreaks of measles in the state. Data were analyzed using the Statistical Package for Social Sciences (SPSS) windows version 22. A total of 4242 cases were reported during the study period. 3780(89.1%) in 2016 (before mass vaccination) and 462(10.9%) were reported in 2017 (after mass vaccination). A total of 556 deaths with case fatality rate of 13.1% was recorded during the study period. Majority of the deaths 525(94.4%) occurred in 2016 when there was no mass vaccination while few 31(5.6%) occurred in 2017 after the mass vaccination. Mass vaccination resulted in a 78.2% decline in number of cases and 88.8% decline in the number of deaths from measles. There was a statistical significant difference in the number of cases and mortality from measles pre and post mass vaccination against the disease in Yobe state. Paired sample t-test done revealed a monthly case distribution mean of 276.6 (95% CI 89.8 to 463.3) with alpha set at 0.05, P = 0.008 while monthly mortality mean was 41.1 (95% CI 15.5 to 66.7) with alpha set at 0.05, P = 0.005. Mass vaccination against measles therefore confers immunity and herd immunity to populations with a subsequent significant decline in morbidity and mortality associated with the measles infection. It is therefore recommended that this initiative be sustained for every two years or possibly yearly to ensure elimination of measles in the Sub-Saharan Africa region and the World at large.

Keywords : Effectiveness, Measles, Mass Vaccination, Morbidity, Mortality.

References :

1. Biellik, R., Madema, S., Taole, A., Kutsulukuta, A., Allies, E., Eggers, R., Ngcobo, N., Nxumalo, M., Shearley, A., Mabuzane, E., Kufa, E., & Okwo-Bele, J. M. (2002). First 5 years of measles elimination in southern Africa: 1996-2000. Lancet (London, England), 359(9317), 1564–1568. https://doi.org/10.1016/S0140-6736(02)08517-3.
2. Bino, S., Kakarriqi, E., Xibinaku, M., Ion-Nedelcu, N., Bukli, M., Emiroglu, N., & Uzicanin, A. (2003). Measles-rubella mass immunization campaign in Albania, November 2000. The Journal of infectious diseases, 187 Suppl 1, S223–S229. https://doi.org/10.1086/368055.
3. Brieger, D., Edwards, M., Mudgil, P., & Whitehall, J. (2017). Knowledge, attitudes and opinions towards measles and the MMR vaccine across two NSW cohorts. Australian and New Zealand Journal of Public Health, 41(6), 641-646. https://doi.org/10.1111/1753-6405.12720
4. Centre for Disease Control and Prevention (CDC, 2023). What CDC is Doing About Global Measles and Rubella Available at: https://www.cdc.gov/globalhealth/measles/what/index.html#:~:text=Today%2C%20every%20region%20in%20the,save%20over%2057%20million%20lives. Accessed 3^rd April, 2024.
5. Chow, A., & Leo, Y. (2016). Surveillance of Disease: Overview. International Encyclopedia of Public Health (Second Edition), 124-138. https://doi.org/10.1016/B978-0-12-803678-5.00439-2.
6. Doumtsop, G.J.,  Malano,  R.E, Diallo, T I et al. (2014). An evaluation of the 2012 measles mass vaccination campaign in Guinea. Pan Afr Med J., 17: 4.
7. Elbasha, E. H., & Gumel, A. B. (2021). Vaccination and herd immunity thresholds in heterogeneous populations. Journal of Mathematical Biology, 83(6-7). https://doi.org/10.1007/s00285-021-01686-z.
8. GebreEyesus, F.A., Tarekegn, T.T., Amlak, B.T., Shiferaw, B.Z., Emeria, M.S., Geleta, O.T., Mewahegn, A.A., Feleke, D.G., & Chanie, E.S. (2019). Knowledge, Attitude, and Practices of Parents About Immunization of Infants and Its Associated Factors in Wadla Woreda, North East Ethiopia. Pediatric Health Med Ther. 2021;12:223-238.
9. Goodson, J. L., Sosler, S., Pasi, O., Johnson, T., Kobella, M., Monono, M. E., & Uzicanin, A. (2011). Impact of a measles outbreak response immunization campaign: Maroua, Cameroon, 2009. The Journal of infectious diseases, 204 Suppl 1, S252–S259. https://doi.org/10.1093/infdis/jir151.
10. Guerra, F.M., Bolotin, S., Lim, G., Heffernan, J., Deeks, S.L., Li, Y., & Crowcroft, N.S. (2017). The basic reproduction number (R0) of measles: a systematic review. Lancet Infect Dis. 17(12):e420-e428. doi: 10.1016/S1473-3099(17)30307-9.
11. Haenssgen M.J., Closser S., & Alonge, O. (2021). Impact and effect mechanisms of mass campaigns in resource-constrained health systems: quasi-experimental evidence from polio eradication in Nigeria. BMJ Global Health. 6(3):e004248. doi: 10.1136/bmjgh-2020-004248.
12. Ibrahim, A. M., Hendawy, H. A. M., Hassan, W. S., Shalaby, A., & El-Sayed, H. M. (2019). Data on validation using accuracy profile of HPLC-UV method. Data in brief, 24, 103877. https://doi.org/10.1016/j.dib.2019.103877.
13. Jean Baptiste, A. E., Masresha, B., Wagai, J., Luce, R., Oteri, J., Dieng, B., Bawa, S., Ikeonu, O. C., Chukwuji, M., Braka, F., Sanders, E., Hahné, S., & Hak, E. (2021). Trends in measles incidence and measles vaccination coverage in Nigeria, 2008–2018. Vaccine, 39, C89-C95. https://doi.org/10.1016/j.vaccine.2021.03.095.
14. Magawa, R. (2012). Primary health care implementation; a brief review. Available at: www.consultancyafrica.com/ index. Accessed 10^th July, 2021.
15. Mahachi, K., Kessels, J., Boateng, K., Jean Baptiste, A. E., Mitula, P., Ekeman, E., Lochlainn, L. N., Rosewell, A., Sodha, S. V., Abela-Ridder, B., & Gabrielli, A. F. (2022). Zero- or missed-dose children in Nigeria: Contributing factors and interventions to overcome immunization service delivery challenges. Vaccine, 40(37), 5433-5444. https://doi.org/10.1016/j.vaccine.2022.07.058.
16. Majekodunmi, O. B., Oladele, E. A., & Greenwood, B. (2022). Factors affecting poor measles vaccination coverage in sub-Saharan Africa with a special focus on Nigeria: A narrative review. Transactions of The Royal Society of Tropical Medicine and Hygiene, 116(8), 686-693. https://doi.org/10.1093/trstmh/trac013.
17. Mbabazi, W. B., Nanyunja, M., Makumbi, I., Braka, F., Baliraine, F. N., Kisakye, A., Bwogi, J., Mugyenyi, P., Kabwongera, E., & Lewis, R. F. (2009). Achieving measles control: Lessons from the 2002–06 measles control strategy for Uganda. Health Policy and Planning, 24(4), 261-269. https://doi.org/10.1093/heapol/czp008.
18. Minta, A. A., Ferrari, M., Antoni, S., Portnoy, A., Sbarra, A., Lambert, B., Hatcher, C., Hsu, C. H., Ho, L. L., Steulet, C., Gacic-Dobo, M., Rota, P. A., Mulders, M. N., Bose, A. S., Caro, W. P., & Crowcroft, N. S. (2023). Progress Toward Measles Elimination — Worldwide, 2000–2022. Morbidity and Mortality Weekly Report, 72(46), 1262-1268. https://doi.org/10.15585/mmwr.mm7246a3
19. Olise, P. (2007). Primary Health Care for Sustainable Development. Abuja: 2^nd Edition, Ozege Publications Abuja. Pp 16 – 22.
20. Ophori, E. A., Tula, M. Y., Azih, A. V., Okojie, R., & Ikpo, P. E. (2014). Current Trends of Immunization in Nigeria: Prospect and Challenges. Tropical Medicine and Health, 42(2), 67-75. https://doi.org/10.2149/tmh.2013-13.
21. Orenstein, W. A., Strebel, P. M., Papania, M., Sutter, R. W., Bellini, W. J., & Cochi, S. L. (2000). Measles eradication: Is it in our future? American Journal of Public Health, 90(10), 1521-1525. https://doi.org/10.2105/ajph.90.10.1521.
22. Pandey, S., Ranjan, A., Singh, C. M., Kumar, P., Ahmad, S., & Agrawal, N. (2019). Socio-demographic determinants of childhood immunization coverage in rural population of Bhojpur district of Bihar, India. Journal of Family Medicine and Primary Care, 8(7), 2484-2489. https://doi.org/10.4103/jfmpc.jfmpc_356_19.
23. Pires C. Global Predictors of COVID-19 Vaccine Hesitancy: A Systematic Review. Vaccines (Basel). 2022 Aug 18;10(8):1349. doi: 10.3390/vaccines10081349. PMID: 36016237; PMCID: PMC9415631.
24. Plans-Rubió, P. (2020). Are the Objectives Proposed by the WHO for Routine Measles Vaccination Coverage and Population Measles Immunity Sufficient to Achieve Measles Elimination from Europe? Vaccines, 8(2). https://doi.org/10.3390/vaccines8020218.
25. Portnoy, A., Jit, M., Helleringer, S., & Verguet, S. (2018). Impact of measles supplementary immunization activities on reaching children missed by routine programs. Vaccine, 36(1), 170–178. https://doi.org/10.1016/j.vaccine.2017.10.080.
26. Sato, R., Makinde, O. A., Daam, K. C., & Lawal, B. (2022). Geographical and time trends of measles incidence and measles vaccination coverage and their correlation in Nigeria. Human Vaccines & Immunotherapeutics, 18(6). https://doi.org/10.1080/21645515.2022.2114697.
27. Uddin, M. J., Adhikary, G., Ali, M. W., Ahmed, S., Shamsuzzaman, M., Odell, C., Hashiguchi, L., Lim, S. S., & Alam, N. (2016). Evaluation of impact of measles rubella campaign on vaccination coverage and routine immunization services in Bangladesh. BMC infectious diseases, 16, 411. https://doi.org/10.1186/s12879-016-1758-x.
28. United Nations Children Fund (UNICEF, 2019). More than 140,000 die from measles as cases surge worldwide. Available at: https://www.unicef.org/press-releases/more-140000-die-measles-cases-surge-worldwide#:~:text=Most%20deaths%20. Accessed 10th July, 2021.
29. Wong, B. K., Fadel, S. A., Awasthi, S., Khera, A., Kumar, R., Menon, G., & Jha, P. (2019). The impact of measles immunization campaigns in India using a nationally representative sample of 27,000 child deaths. eLife, 8, e43290. https://doi.org/10.7554/eLife.43290.
30. World Health Organization. (WHO, 2005). Measles mortality reduction and regional elimination strategic plan 2001–2005, 2001GenevaWHO (WHO/V&B/01.13).
31. World Health Organization. (WHO, 2017). WHO position paper – April 2017. Available at: https://www.who.int/publications/i/item/who-wer9217-205-227. Accessed 3^rd May, 2024.
32. World Health Organization. (WHO, 2022). Measles Outbreak Guide. License: CC BY-NC-SA 3.0 IGO. Pp. 9 – 32.
33. World Health Organization. (WHO, 2024). Measles. Available at: https://www.who.int/news-room/fact-sheets/detail/measles. Accessed 3^rd May, 2024.